85 results on '"Vaiva Vezys"'
Search Results
2. Novel Lymphocytic Choriomeningitis Virus Strain Sustains Abundant Exhausted Progenitor CD8 T Cells without Systemic Viremia
- Author
-
Lalit K. Beura, Milcah C. Scott, Mark J. Pierson, Vineet Joag, Sathi Wijeyesinghe, Matthew R. Semler, Clare F. Quarnstrom, Kathleen Busman-Sahay, Jacob D. Estes, Sara E. Hamilton, Vaiva Vezys, David H. O’Connor, and David Masopust
- Subjects
Mice, Inbred C57BL ,Mice ,Programmed Cell Death 1 Receptor ,Immunology ,Animals ,Lymphocytic choriomeningitis virus ,Immunology and Allergy ,Viremia ,Amino Acids ,CD8-Positive T-Lymphocytes ,Lymphocytic Choriomeningitis ,Hepatitis A Virus Cellular Receptor 2 - Abstract
Lymphocytic choriomeningitis virus (LCMV) is the prototypic arenavirus and a natural mouse pathogen. LCMV-Armstrong, an acutely resolved strain, and LCMV-clone 13, a mutant that establishes chronic infection, have provided contrasting infection models that continue to inform the fundamental biology of T cell differentiation, regulation of exhaustion, and response to checkpoint blockade. In this study, we report the isolation and characterization of LCMV-Minnesota (LCMV-MN), which was naturally transmitted to laboratory mice upon cohousing with pet shop mice and shares 80–95% amino acid homology with previously characterized LCMV strains. Infection of laboratory mice with purified LCMV-MN resulted in viral persistence that was intermediate between LCMV-Armstrong and -clone 13, with widely disseminated viral replication and viremia that was controlled within 15–30 d, unless CD4 T cells were depleted prior to infection. LCMV-MN–responding CD8+ T cells biased differentiation toward the recently described programmed death-1 (PD-1)+CXCR5+Tim-3lo stemlike CD8+ T cell population (also referred to as progenitor exhausted T cells) that effectuates responses to PD-1 blockade checkpoint inhibition, a therapy that rejuvenates responses against chronic infections and cancer. This subset resembled previously characterized PD-1+TCF1+ stemlike CD8+ T cells by transcriptional, phenotypic, and functional assays, yet was atypically abundant. LCMV-MN may provide a tool to better understand the breadth of immune responses in different settings of chronic Ag stimulation as well as the ontogeny of progenitor exhausted T cells and the regulation of responsiveness to PD-1 blockade.
- Published
- 2022
3. Depleting CD103+ resident memory T cells in vivo reveals immunostimulatory functions in oral mucosa
- Author
-
J. Michael Stolley, Milcah C. Scott, Vineet Joag, Alexander J. Dale, Timothy S. Johnston, Flavia Saavedra, Noah V. Gavil, Sahar Lotfi-Emran, Andrew G. Soerens, Eyob Weyu, Mark J. Pierson, Mark C. Herzberg, Nu Zhang, Vaiva Vezys, and David Masopust
- Subjects
Immunology ,Immunology and Allergy - Abstract
The oral mucosa is a frontline for microbial exposure and juxtaposes several unique tissues and mechanical structures. Based on parabiotic surgery of mice receiving systemic viral infections or co-housing with microbially diverse pet shop mice, we report that the oral mucosa harbors CD8+ CD103+ resident memory T cells (TRM), which locally survey tissues without recirculating. Oral antigen re-encounter during the effector phase of immune responses potentiated TRM establishment within tongue, gums, palate, and cheek. Upon reactivation, oral TRM triggered changes in somatosensory and innate immune gene expression. We developed in vivo methods for depleting CD103+ TRM while sparing CD103neg TRM and recirculating cells. This revealed that CD103+ TRM were responsible for inducing local gene expression changes. Oral TRM putatively protected against local viral infection. This study provides methods for generating, assessing, and in vivo depleting oral TRM, documents their distribution throughout the oral mucosa, and provides evidence that TRM confer protection and trigger responses in oral physiology and innate immunity.
- Published
- 2023
4. Transient T Cell Expansion, Activation, and Proliferation in Therapeutically Vaccinated Simian Immunodeficiency Virus-Positive Macaques Treated with N-803
- Author
-
Olivia E. Harwood, Alexis J. Balgeman, Abigail J. Weaver, Amy L. Ellis-Connell, Andrea M. Weiler, Katrina N. Erickson, Lea M. Matschke, Athena E. Golfinos, Vaiva Vezys, Pamela J. Skinner, Jeffrey T. Safrit, Paul T. Edlefsen, Matthew R. Reynolds, Thomas C. Friedrich, and Shelby L. O’Connor
- Subjects
Vaccination ,Immunology ,SAIDS Vaccines ,Simian Acquired Immunodeficiency Syndrome ,Vaccinia virus ,CD8-Positive T-Lymphocytes ,Macaca mulatta ,Microbiology ,Virology ,Insect Science ,Vaccines and Antiviral Agents ,Animals ,Simian Immunodeficiency Virus ,Cell Proliferation - Abstract
Vaccine strategies aimed at eliciting human immunodeficiency virus (HIV)-specific CD8(+) T cells are one major target of interest in HIV functional cure strategies. We hypothesized that CD8(+) T cells elicited by therapeutic vaccination during antiretroviral therapy (ART) would be recalled and boosted by treatment with the interleukin 15 (IL-15) superagonist N-803 after ART discontinuation. We intravenously immunized four simian immunodeficiency virus-positive (SIV(+)) Mauritian cynomolgus macaques receiving ART with vesicular stomatitis virus (VSV), modified vaccinia virus Ankara strain (MVA), and recombinant adenovirus serotype 5 (rAd-5) vectors all expressing SIVmac239 Gag. Immediately after ART cessation, these animals received three doses of N-803. Four control animals received no vaccines or N-803. The vaccine regimen generated a high-magnitude response involving Gag-specific CD8(+) T cells that were proliferative and biased toward an effector memory phenotype. We then compared cells elicited by vaccination (Gag specific) to cells elicited by SIV infection and unaffected by vaccination (Nef specific). We found that N-803 treatment enhanced the frequencies of both bulk and proliferating antigen-specific CD8(+) T cells elicited by vaccination and the antigen-specific CD8(+) T cells elicited by SIV infection. In sum, we demonstrate that a therapeutic heterologous prime-boost-boost (HPBB) vaccine can elicit antigen-specific effector memory CD8(+) T cells that are boosted by N-803. IMPORTANCE While antiretroviral therapy (ART) can suppress HIV replication, it is not a cure. It is therefore essential to develop therapeutic strategies to enhance the immune system to better become activated and recognize virus-infected cells. Here, we evaluated a novel therapeutic vaccination strategy delivered to SIV(+) Mauritian cynomolgus macaques receiving ART. ART was then discontinued and we delivered an immunotherapeutic agent (N-803) after ART withdrawal with the goal of eliciting and boosting anti-SIV cellular immunity. Immunologic and virologic analysis of peripheral blood and lymph nodes collected from these animals revealed transient boosts in the frequency, activation, proliferation, and memory phenotype of CD4(+) and CD8(+) T cells following each intervention. Overall, these results are important in educating the field of the transient nature of the immunological responses to this particular therapeutic regimen and the similar effects of N-803 on boosting T cells elicited by vaccination or elicited naturally by infection.
- Published
- 2022
5. 1027 Chronic antigen in solid tumors drives a distinct program of T cell residence
- Author
-
Noah Gavil, Milcah Scott, Eyob Weyu, Olivia Smith, Stephen O'Flanagan, Sathi Wijeyesinghe, Sahar Lotfi-Emran, Stephen Shiao, Vaiva Vezys, and David Masopust
- Published
- 2022
6. Transient T cell expansion, activation, and proliferation in therapeutically vaccinated SIV+ macaques treated with N-803
- Author
-
Olivia E. Harwood, Alexis J. Balgeman, Abigail J. Weaver, Amy L. Ellis-Connell, Andrea M. Weiler, Katrina N. Erickson, Lea M. Matschke, Athena E. Golfinos, Vaiva Vezys, Pamela J. Skinner, Jeffrey T. Safrit, Paul T. Edlefsen, Matthew R. Reynolds, Thomas C. Friedrich, and Shelby L. O’Connor
- Abstract
Vaccine strategies aimed at eliciting HIV-specific CD8+ T cells are one major target of interest in HIV functional cure strategies. We hypothesized that CD8+ T cells elicited by therapeutic vaccination during antiretroviral therapy (ART) would be recalled and boosted by treatment with the IL-15 superagonist N-803 after ART discontinuation. We intravenously immunized four SIV+ Mauritian cynomolgus macaques (MCM) receiving ART with vesicular stomatitis virus (VSV), modified vaccinia virus Ankara strain (MVA), and recombinant adenovirus serotype 5 (rAd-5) vectors all expressing SIVmac239 Gag. Immediately after ART cessation, these animals received three doses of N-803. Four control animals received no vaccines or N-803. The vaccine regimen generated a high magnitude of Gag-specific CD8+ T cells that were proliferative and biased toward an effector memory phenotype. We then compared cells elicited by vaccination (Gag-specific) to cells elicited by SIV infection and unaffected by vaccination (Nef-specific). We found that N-803 treatment enhanced both the frequencies of bulk and proliferating antigen-specific CD8+ T cells elicited by vaccination and the antigen-specific CD8+ T cells elicited by SIV infection. In sum, we demonstrate that a therapeutic heterologous prime-boost-boost (HPBB) vaccine can elicit antigen-specific effector memory CD8+ T cells that are boosted by N-803.
- Published
- 2022
7. Route of self-amplifying mRNA vaccination modulates the establishment of pulmonary resident memory CD8 and CD4 T cells
- Author
-
Marco Künzli, Stephen D. O’Flanagan, Madeleine LaRue, Poulami Talukder, Thamotharampillai Dileepan, Andrew G. Soerens, Clare F. Quarnstrom, Sathi Wijeyesinghe, Yanqi Ye, Justine McPartlan, Jason S. Mitchell, Christian W. Mandl, Richard Vile, Marc K. Jenkins, Rafi Ahmed, Vaiva Vezys, Jasdave Chahal, and David Masopust
- Abstract
Respiratory tract resident memory T cells (Trm), typically generated by local vaccination or infection, can accelerate control of pulmonary infections that evade neutralizing antibody. It is unknown whether mRNA vaccination establishes respiratory Trm. We generated a self-amplifying mRNA vaccine encoding the influenza A virus nucleoprotein that is encapsulated in modified dendron-based nanoparticles. Here we report how routes of immunization in mice, including contralateral versus ipsilateral intramuscular boosts, or intravenous and intranasal routes, influence influenza-specific cell-mediated and humoral immunity. Parabiotic surgeries revealed that intramuscular immunization was sufficient to establish CD8 Trm in lung and draining lymph node. Contralateral, compared to ipsilateral, intramuscular boosting broadened the distribution of LN Trm and T follicular helper cells, but slightly diminished resulting levels of serum antibody. Intranasal mRNA delivery established modest circulating CD8 and CD4 T cell memory, but augmented distribution to the respiratory mucosa. Of note, combining intramuscular immunizations with an intranasal mRNA boost achieved high levels of both circulating T cell memory and lung Trm. Thus, routes of mRNA vaccination influence humoral and cell-mediated immunity, and intramuscular prime-boosting establishes lung Trm that can be further enhanced by an additional intranasal immunization.
- Published
- 2022
8. Cutting Edge: Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity
- Author
-
Vineet Joag, Stephen D O'Flanagan, Joshua M. Thiede, Clare F. Quarnstrom, Clayton K. Mickelson, Marc K. Jenkins, J. Michael Stolley, William E. Matchett, Tyler D. Bold, David Masopust, Michelle N Vu, Vaiva Vezys, Frances K. Shepherd, Vineet D. Menachery, Jennifer A Walter, Samuel Becker, Sathi Wijeyesinghe, Ryan A. Langlois, Eyob Weyu, and Andrew G. Soerens
- Subjects
Male ,COVID-19 Vaccines ,viruses ,T cell ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Immunology ,Biology ,CD8-Positive T-Lymphocytes ,Antibodies, Viral ,Epitope ,Article ,Cell Line ,Mice ,Immunity ,Cricetinae ,Pandemic ,Chlorocebus aethiops ,medicine ,Immunology and Allergy ,Animals ,Coronavirus Nucleocapsid Proteins ,Vector (molecular biology) ,Lymphocyte Count ,Vero Cells ,SARS-CoV-2 ,Vaccination ,COVID-19 ,Phosphoproteins ,Virology ,Antibodies, Neutralizing ,Mice, Inbred C57BL ,medicine.anatomical_structure ,biology.protein ,Female ,Antibody ,Viral load ,Immunologic Memory - Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. Neutralizing Abs target the receptor binding domain of the spike (S) protein, a focus of successful vaccine efforts. Concerns have arisen that S-specific vaccine immunity may fail to neutralize emerging variants. We show that vaccination with a human adenovirus type 5 vector expressing the SARS-CoV-2 nucleocapsid (N) protein can establish protective immunity, defined by reduced weight loss and viral load, in both Syrian hamsters and K18-hACE2 mice. Challenge of vaccinated mice was associated with rapid N-specific T cell recall responses in the respiratory mucosa. This study supports the rationale for including additional viral Ags in SARS-CoV-2 vaccines, even if they are not a target of neutralizing Abs, to broaden epitope coverage and immune effector mechanisms.
- Published
- 2021
9. Reprogramming responsiveness to checkpoint blockade in dysfunctional CD8 T cells
- Author
-
Vaiva Vezys, Emily A. Thompson, Lauren J. Mills, Jennifer L. McCurtain, Clare F. Quarnstrom, Christine E. Nelson, Brian T. Fife, Davis M. Seelig, and Siddheshvar Bhela
- Subjects
0301 basic medicine ,T cell ,CD8-Positive T-Lymphocytes ,Lymphocyte Activation ,medicine.disease_cause ,B7-H1 Antigen ,Autoimmunity ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Antigen ,Immune Tolerance ,medicine ,Animals ,Cytotoxic T cell ,Antigens ,Mechanistic target of rapamycin ,Cell Proliferation ,Multidisciplinary ,biology ,Effector ,Biological Sciences ,Cellular Reprogramming ,Blockade ,Mice, Inbred C57BL ,030104 developmental biology ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,biology.protein ,Cancer research ,Reprogramming - Abstract
Established T cell dysfunction is a barrier to antitumor responses, and checkpoint blockade presumably reverses this. Many patients fail to respond to treatment and/or develop autoimmune adverse events. The underlying reason for T cell responsiveness remains elusive. Here, we show that susceptibility to checkpoint blockade is dependent on the activation status of T cells. Newly activated self-specific CD8 T cells respond to checkpoint blockade and cause autoimmunity, which is mitigated by inhibiting the mechanistic target of rapamycin. However, once tolerance is established, self-specific CD8 T cells display a gene signature comparable to tumor-specific CD8 T cells in a fixed state of dysfunction. Tolerant self-specific CD8 T cells do not respond to single or combinatorial dosing of anti-CTLA4, anti–PD-L1, anti–PD-1, anti–LAG-3, and/or anti–TIM-3. Despite this, T cell responsiveness can be induced by vaccination with cognate antigen, which alters the previously fixed transcriptional signature and increases antigen-sensing machinery. Antigenic reeducation of tolerant T cells synergizes with checkpoint blockade to generate functional CD8 T cells, which eliminate tumors without concomitant autoimmunity and are transcriptionally distinct from classic effector T cells. These data demonstrate that responses to checkpoint blockade are dependent on the activation state of a T cell and show that checkpoint blockade-insensitive CD8 T cells can be induced to respond to checkpoint blockade with robust antigenic stimulation to participate in tumor control.
- Published
- 2019
10. Sensing and alarm function of vaccine-elicited SIV-gag specific CD8 TRM in the reproductive mucosa of rhesus macaques
- Author
-
Vineet Joag, Clare Quarnstrom, Andrew Soerens, James Michael Stolley, Jason M Schenkel, Kathryn Fraser, Vaiva Vezys, Pamela J Skinner, Eric Hunter, Benjamin Bimber, Rama Rao Amara, and David Masopust
- Subjects
Immunology ,Immunology and Allergy - Abstract
TRM constitute a recently identified lymphocyte lineage that occupies non-lymphoid tissues (NLT) without recirculating. Experiments in mice demonstrated that TRM reactivation triggers antiviral responses in neighboring cells by promoting local stimulation of innate and adaptive immune cells, and by recruiting immune effectors. Collectively this is referred to as ‘sensing and alarm’ function. We wished to broadly identify TRM functions in non-human primates (NHP). Here we applied a prime-boost vaccine modality in rhesus macaques to generate abundant SIVgag-specific CD8 TRM in the female reproductive tract (FRT) and 14 other NLT. To assess sensing and alarm function, macaques were challenged intravaginally with CM9 peptide from the SIV gag protein and necropsied 24 or 48 hours later. CD8 TRM reactivation increased expression of CD69 and granzyme B in SIV-gag specific CD8 T cells throughout the FRT at 24h, in situ proliferation (Ki67 expression) by 48h, and rapid antiviral and IFN response gene expression in essentially all hematopoietic and non-hematopoietic cells by 24h. Upregulation of effector genes in CD8 T cells, CD4 T cells, NK cells, and ILCs peaked at 24h and persisted at 48h. Mucosal CD4 T cells expressed various HIV restriction factors, and had reduced expression of the HIV-coreceptor CCR5. Increased numbers of vaginal T and B cells coincided with increased expression of chemokines and VCAM-1 on endothelial and stromal cells and a concomitant reduction in circulating T cells, B cells and SIV-env-specific B cells. These data demonstrate that vaccine-elicited CD8 TRM rapidly trigger local activation and the recruitment of innate, cellular, and humoral immune responses to the site of antigen exposure.
- Published
- 2022
11. Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses
- Author
-
J. Michael Stolley, Peter J. Southern, Siddheshvar Bhela, Thamotharampillai Dileepan, Maxim C.-J. Cheeran, Vineet Joag, Marc K. Jenkins, Sathi Wijeyesinghe, Joshua M. Thiede, Luca Schifanella, Jules A. Sangala, Clare F. Quarnstrom, Geoffrey T. Hart, Stephen D O'Flanagan, Sung-Wook Hong, Venkatramana D. Krishna, William E. Matchett, Noah V. Gavil, David Masopust, Sailaja Gangadhara, Tyler D. Bold, Eyob Weyu, Ryan A. Langlois, Vaiva Vezys, Rama Rao Amara, and Andrew G. Soerens
- Subjects
COVID-19 Vaccines ,T cell ,viruses ,Immunology ,Genetic Vectors ,Heterologous ,Epitopes, T-Lymphocyte ,Mice, Transgenic ,Biology ,CD8-Positive T-Lymphocytes ,Epitope ,Article ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Immunity ,HLA-A2 Antigen ,medicine ,Immunology and Allergy ,Cytotoxic T cell ,Animals ,Coronavirus Nucleocapsid Proteins ,Humans ,Cells, Cultured ,SARS-CoV-2 ,Vaccination ,COVID-19 ,Virology ,Mice, Inbred C57BL ,Disease Models, Animal ,medicine.anatomical_structure ,Immunization ,Humoral immunity ,Female ,Angiotensin-Converting Enzyme 2 ,030215 immunology - Abstract
The magnitude of SARS-CoV-2–specific T cell responses correlates inversely with human disease severity, suggesting T cell involvement in primary control. Whereas many COVID-19 vaccines focus on establishing humoral immunity to viral spike protein, vaccine-elicited T cell immunity may bolster durable protection or cross-reactivity with viral variants. To better enable mechanistic and vaccination studies in mice, we identified a dominant CD8 T cell SARS-CoV-2 nucleoprotein epitope. Infection of human ACE2 transgenic mice with SARS-CoV-2 elicited robust responses to H2-Db/N219-227, and 40% of HLA-A*02+ COVID-19 PBMC samples isolated from hospitalized patients responded to this peptide in culture. In mice, i.m. prime-boost nucleoprotein vaccination with heterologous vectors favored systemic CD8 T cell responses, whereas intranasal boosting favored respiratory immunity. In contrast, a single i.v. immunization with recombinant adenovirus established robust CD8 T cell memory both systemically and in the respiratory mucosa.
- Published
- 2020
12. Expansible residence decentralizes immune homeostasis
- Author
-
J. Michael Stolley, Elizabeth M. Steinert, Omar A. Adam, David Masopust, Lalit K. Beura, Sathi Wijeyesinghe, Mark Pierson, Roland Ruscher, Vaiva Vezys, and Pamela C. Rosato
- Subjects
0301 basic medicine ,Male ,Cellular immunity ,Parabiosis ,Receptors, Antigen, T-Cell ,chemical and pharmacologic phenomena ,Biology ,Adaptive Immunity ,CD8-Positive T-Lymphocytes ,Article ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Immune system ,Immunity ,Animals ,Homeostasis ,Immunologic Surveillance ,Tissue homeostasis ,Multidisciplinary ,Acquired immune system ,Immunity, Innate ,Cell biology ,Mice, Inbred C57BL ,Haematopoiesis ,030104 developmental biology ,Cellular Microenvironment ,Female ,Immunologic Memory ,030215 immunology - Abstract
In metazoans, specific tasks are relegated to dedicated organs that are established early in development, occupy discrete locations and typically remain fixed in size. The adult immune system arises from a centralized haematopoietic niche that maintains self-renewing potential1,2, and—upon maturation—becomes distributed throughout the body to monitor environmental perturbations, regulate tissue homeostasis and mediate organism-wide defence. Here we examine how immunity is integrated within adult mouse tissues, and address issues of durability, expansibility and contributions to organ cellularity. Focusing on antiviral T cell immunity, we observed durable maintenance of resident memory T cells up to 450 days after infection. Once established, resident T cells did not require the T cell receptor for survival or retention of a poised, effector-like state. Although resident memory indefinitely dominated most mucosal organs, surgical separation of parabiotic mice revealed a tissue-resident provenance for blood-borne effector memory T cells, and circulating memory slowly made substantial contributions to tissue immunity in some organs. After serial immunizations or cohousing with pet-shop mice, we found that in most tissues, tissue pliancy (the capacity of tissues to vary their proportion of immune cells) enables the accretion of tissue-resident memory, without axiomatic erosion of pre-existing antiviral T cell immunity. Extending these findings, we demonstrate that tissue residence and organ pliancy are generalizable aspects that underlie homeostasis of innate and adaptive immunity. The immune system grows commensurate with microbial experience, reaching up to 25% of visceral organ cellularity. Regardless of the location, many populations of white blood cells adopted a tissue-residency program within nonlymphoid organs. Thus, residence—rather than renewal or recirculation—typifies nonlymphoid immune surveillance, and organs serve as pliant storage reservoirs that can accommodate continuous expansion of the cellular immune system throughout life. Although haematopoiesis restores some elements of the immune system, nonlymphoid organs sustain an accrual of durable tissue-autonomous cellular immunity that results in progressive decentralization of organismal immune homeostasis. Investigations in mice using parabiosis and cohousing experiments reveal that nonlymphoid organs serve as reservoirs of tissue-autonomous cellular immunity, leading to the decentralization of organism-level immune homeostasis.
- Published
- 2020
13. Mice with diverse microbial exposure histories as a model for preclinical vaccine testing
- Author
-
David K. Meyerholz, J. Michael Stolley, Hezkiel Nanda, Clayton K. Mickelson, Frances K. Shepherd, Sathi Wijeyesinghe, Vaiva Vezys, Sara E. Hamilton, Mark Pierson, Steven S. Shen, Ryan A. Langlois, Jessica K. Fiege, David Masopust, Katharine E. Block, and William E. Matchett
- Subjects
Male ,Mice, Inbred BALB C ,Vaccination ,Biology ,Microbiology ,Immunity, Humoral ,Mice, Inbred C57BL ,Mice ,Immunogenicity, Vaccine ,Immune system ,Vaccine Immunogenicity ,Poor control ,Influenza Vaccines ,Immunity ,Virology ,Immunology ,Humoral immunity ,Post vaccination ,Vaccine Testing ,Animals ,Humans ,Female ,Parasitology ,Spotlight - Abstract
Summary In a recent issue of Cell Host and Microbe, Fiege and colleagues1 report that laboratory mice exposed to pathogens from pet-store mice exhibit impaired humoral immunity to influenza vaccination and display gene expression signatures that more authentically reflect human vaccine responses., In a recent issue of Cell Host and Microbe, Fiege and colleagues1 report that laboratory mice exposed to pathogens from pet-store mice exhibit impaired humoral immunity to influenza vaccination and display gene expression signatures that more authentically reflect human vaccine responses.
- Published
- 2021
14. Tumor-Targeted Low-dose Radiation and Immunotherapy in Mouse Models of Melanoma
- Author
-
J. Lawrence, A. Rossetti-Chung, P. Alaei, Vaiva Vezys, L. Claps, C.T. Wilke, and Siddheshvar Bhela
- Subjects
Cancer Research ,Radiation ,business.industry ,Melanoma ,medicine.medical_treatment ,Immunotherapy ,medicine.disease ,Tumor targeted ,Oncology ,Cancer research ,Medicine ,Radiology, Nuclear Medicine and imaging ,business ,Low Dose Radiation - Published
- 2020
15. A Transgenic Melanoma Cell Line for quantifying Tumor Mutational Burden and tracking Tumor-specific CD8+ T-cell Responses
- Author
-
C.T. Wilke, Brian T. Fife, A. Rossetti-Chung, Vaiva Vezys, Siddheshvar Bhela, and C. Tucker
- Subjects
Cancer Research ,Radiation ,Oncology ,business.industry ,Transgene ,Melanoma cell line ,Cancer research ,Tumor specific ,Cytotoxic T cell ,Medicine ,Radiology, Nuclear Medicine and imaging ,business - Published
- 2020
16. Developmental plasticity allows outside-in immune responses by resident memory T cells
- Author
-
Nancy J. Fares-Frederickson, Vaiva Vezys, Emily A. Thompson, Henrique Borges da Silva, Sathi Wijeyesinghe, Caitlin C. Zebley, Clare F. Quarnstrom, Hazem E. Ghoneim, Lalit K. Beura, Raissa Fonseca, David Masopust, Yiping Fan, Benjamin Youngblood, and Milcah C. Scott
- Subjects
0301 basic medicine ,T cell ,Cellular differentiation ,Immunology ,Cell Plasticity ,Biology ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Immune system ,Intestinal mucosa ,T-Lymphocyte Subsets ,Intestine, Small ,medicine ,Immunology and Allergy ,Animals ,Epigenetics ,Intestinal Mucosa ,Effector ,Cell Differentiation ,Cell biology ,Mice, Inbred C57BL ,030104 developmental biology ,medicine.anatomical_structure ,Female ,Immunologic Memory ,030215 immunology ,Homing (hematopoietic) - Abstract
Central memory T (TCM) cells patrol lymph nodes and perform conventional memory responses on restimulation: proliferation, migration and differentiation into diverse T cell subsets while also self-renewing. Resident memory T (TRM) cells are parked within single organs, share properties with terminal effectors and contribute to rapid host protection. We observed that reactivated TRM cells rejoined the circulating pool. Epigenetic analyses revealed that TRM cells align closely with conventional memory T cell populations, bearing little resemblance to recently activated effectors. Fully differentiated TRM cells isolated from small intestine epithelium exhibited the potential to differentiate into TCM cells, effector memory T cells and TRM cells on recall. Ex-TRM cells, former intestinal TRM cells that rejoined the circulating pool, heritably maintained a predilection for homing back to their tissue of origin on subsequent reactivation and a heightened capacity to redifferentiate into TRM cells. Thus, TRM cells can rejoin the circulation but are advantaged to re-form local TRM when called on.
- Published
- 2019
17. Virus-specific memory T cells populate tumors and can be repurposed for tumor immunotherapy
- Author
-
Luke S. Manlove, J. Michael Stolley, Christine E. Nelson, Vaiva Vezys, Pamela C. Rosato, Bruce R. Blazar, David Masopust, Christopher A. Pennell, Rachel L. Davis, Melissa A. Geller, Clark C. Chen, and Sathi Wijeyesinghe
- Subjects
Male ,0301 basic medicine ,medicine.medical_treatment ,General Physics and Astronomy ,02 engineering and technology ,CD8-Positive T-Lymphocytes ,Mice ,Cancer immunotherapy ,Neoplasms ,Tumor Microenvironment ,Cytotoxic T cell ,Child ,lcsh:Science ,Aged, 80 and over ,Multidisciplinary ,Middle Aged ,021001 nanoscience & nanotechnology ,Acquired immune system ,Female ,Immunotherapy ,0210 nano-technology ,Adult ,Adolescent ,Science ,Antigen presentation ,Biology ,Article ,General Biochemistry, Genetics and Molecular Biology ,Young Adult ,03 medical and health sciences ,Antigen ,Antigens, Neoplasm ,Cell Line, Tumor ,medicine ,Animals ,Humans ,Aged ,Tumor microenvironment ,General Chemistry ,biochemical phenomena, metabolism, and nutrition ,Mice, Inbred C57BL ,030104 developmental biology ,Microscopy, Fluorescence ,Cancer research ,bacteria ,lcsh:Q ,CD8 ,T-Lymphocytes, Cytotoxic - Abstract
The immunosuppressive tumor microenvironment limits the success of current immunotherapies. The host retains memory T cells specific for previous infections throughout the entire body that are capable of executing potent and immediate immunostimulatory functions. Here we show that virus-specific memory T cells extend their surveillance to mouse and human tumors. Reactivating these antiviral T cells can arrest growth of checkpoint blockade-resistant and poorly immunogenic tumors in mice after injecting adjuvant-free non-replicating viral peptides into tumors. Peptide mimics a viral reinfection event to memory CD8+ T cells, triggering antigen presentation and cytotoxic pathways within the tumor, activating dendritic cells and natural killer cells, and recruiting the adaptive immune system. Viral peptide treatment of ex vivo human tumors recapitulates immune activation gene expression profiles observed in mice. Lastly, peptide therapy renders resistant mouse tumors susceptible to PD-L1 blockade. Thus, re-stimulating known antiviral immunity may provide a unique therapeutic approach for cancer immunotherapy., The immunosuppressive tumor environment and the lack of functional anti-tumor immunity are major limiting factors in immunotherapy. Here the authors show that human and mouse tumors are infiltrated by virus-specific memory T cells, which can be harnessed by viral peptides to induce local and systemic anti-tumor immunity and synergize with checkpoint blockade.
- Published
- 2019
18. Normalizing the environment recapitulates adult human immune traits in laboratory mice
- Author
-
Kathryn A. Fraser, Sara E. Hamilton, Marc K. Jenkins, Pamela C. Rosato, Emily A. Thompson, Oludare A. Odumade, Kerry A. Casey, Vaiva Vezys, Kevin Bi, W. Nicholas Haining, Jason M. Schenkel, Ali Filali-Mouhim, Rafick Pierre Sekaly, David Masopust, Lalit K. Beura, and Stephen C. Jameson
- Subjects
0301 basic medicine ,Multidisciplinary ,Cellular differentiation ,Laboratory mouse ,Environmental exposure ,Biology ,Blood cell ,03 medical and health sciences ,030104 developmental biology ,medicine.anatomical_structure ,Immune system ,Immunity ,Immunology ,medicine ,Specific Pathogen Free Organism ,Specific-pathogen-free - Abstract
Our current understanding of immunology was largely defined in laboratory mice, partly because they are inbred and genetically homogeneous, can be genetically manipulated, allow kinetic tissue analyses to be carried out from the onset of disease, and permit the use of tractable disease models. Comparably reductionist experiments are neither technically nor ethically possible in humans. However, there is growing concern that laboratory mice do not reflect relevant aspects of the human immune system, which may account for failures to translate disease treatments from bench to bedside. Laboratory mice live in abnormally hygienic specific pathogen free (SPF) barrier facilities. Here we show that standard laboratory mouse husbandry has profound effects on the immune system and that environmental changes produce mice with immune systems closer to those of adult humans. Laboratory mice--like newborn, but not adult, humans--lack effector-differentiated and mucosally distributed memory T cells. These cell populations were present in free-living barn populations of feral mice and pet store mice with diverse microbial experience, and were induced in laboratory mice after co-housing with pet store mice, suggesting that the environment is involved in the induction of these cells. Altering the living conditions of mice profoundly affected the cellular composition of the innate and adaptive immune systems, resulted in global changes in blood cell gene expression to patterns that more closely reflected the immune signatures of adult humans rather than neonates, altered resistance to infection, and influenced T-cell differentiation in response to a de novo viral infection. These data highlight the effects of environment on the basal immune state and response to infection and suggest that restoring physiological microbial exposure in laboratory mice could provide a relevant tool for modelling immunological events in free-living organisms, including humans.
- Published
- 2016
19. Shortened Intervals during Heterologous Boosting Preserve Memory CD8 T Cell Function but Compromise Longevity
- Author
-
Vaiva Vezys, Emily A. Thompson, Christine E. Nelson, Kristin G. Anderson, and Lalit K. Beura
- Subjects
0301 basic medicine ,Time Factors ,Transgene ,Immunology ,Immunization, Secondary ,Epitopes, T-Lymphocyte ,Heterologous ,Mice, Transgenic ,CD8-Positive T-Lymphocytes ,Biology ,complex mixtures ,Article ,Epitope ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Antigen ,Cell Movement ,medicine ,Animals ,Immunology and Allergy ,Cytotoxic T cell ,Antigens ,Vaccination ,Viral Vaccines ,Bacterial vaccine ,Phenotype ,030104 developmental biology ,medicine.anatomical_structure ,Bacterial Vaccines ,Models, Animal ,Immunologic Memory ,Memory T cell ,030215 immunology - Abstract
Developing vaccine strategies to generate high numbers of Ag-specific CD8 T cells may be necessary for protection against recalcitrant pathogens. Heterologous prime-boost-boost immunization has been shown to result in large quantities of functional memory CD8 T cells with protective capacities and long-term stability. Completing the serial immunization steps for heterologous prime-boost-boost can be lengthy, leaving the host vulnerable for an extensive period of time during the vaccination process. We show in this study that shortening the intervals between boosting events to 2 wk results in high numbers of functional and protective Ag-specific CD8 T cells. This protection is comparable to that achieved with long-term boosting intervals. Short-boosted Ag-specific CD8 T cells display a canonical memory T cell signature associated with long-lived memory and have identical proliferative potential to long-boosted T cells Both populations robustly respond to antigenic re-exposure. Despite this, short-boosted Ag-specific CD8 T cells continue to contract gradually over time, which correlates to metabolic differences between short- and long-boosted CD8 T cells at early memory time points. Our studies indicate that shortening the interval between boosts can yield abundant, functional Ag-specific CD8 T cells that are poised for immediate protection; however, this is at the expense of forming stable long-term memory.
- Published
- 2016
20. Tumor Targeted Low Dose Radiation and Immunotherapy in Mouse Models of Melanoma
- Author
-
Allen Rossetti-Chung, Siddheshvar Bhela, Lindsey Claps, Jessica Lawrence, and Vaiva Vezys
- Subjects
Cancer Research ,Radiation ,Oncology ,Radiology, Nuclear Medicine and imaging - Published
- 2020
21. Harnessing antiviral memory T cells for tumor immunotherapy
- Author
-
Pamela Rosato, Sathi P Wijeyesinghe, Jianfang Ning, Noah Veis Gavil, Shaoping Wu, Clark Chen, Vaiva Vezys, and David Masopust
- Subjects
Immunology ,Immunology and Allergy - Abstract
Overcoming the immunosuppressive tumor microenvironment remains a major impediment to successful cancer immunotherapy. Virus-specific memory T cells are positioned throughout the entire body to sense reinfection or recrudescence. Mouse models have demonstrated upon reencountering cognate antigen, these tissue resident memory T cells (TRM) induce a local immunostimulatory environment that activates and recruits innate and adaptive arms of the immune system, and we extend these functions to include recruitment of circulating antibody. Like healthy tissue, we observe that mouse and human tumors are commonly surveyed by virus-specific memory CD8+ T cells. This was seen in a range of tumor types including traditionally ‘immune-privilege’ tissues such as glioblastoma. Given the described immunostimualtory functions of antiviral TRM in healthy tissue, we tested if we could leverage antiviral CD8+ T cells in tumors as an immunotherapy. Local delivery of adjuvant-free peptide derived from previously encountered viruses successfully reactivated antiviral T cells within melanoma and glioblastoma tumors. This arrested growth of checkpoint blockade-resistant and poorly immunogenic tumors in mice. Antiviral T cell reactivation triggered antigen presentation and cytotoxic pathways within the tumor, activating T cells, dendritic cells and natural killer cells. Viral peptide treatment of ex vivo human tumors demonstrated upregulation of immune activation gene expression profiles similar to those observed in mice. Lastly, viral peptide therapy renders resistant mouse tumors susceptible to PD-L1 blockade. Thus, re-stimulating known antiviral immunity may provide a novel therapeutic approach for a broad range of tumors.
- Published
- 2020
22. Pet shop mice are infected with a novel lymphocytic choriomeningitis virus strain that sustains an abundance of stem-like PD-1+ CD8 T cells
- Author
-
Lalit K Beura, Mark J Pierson, Sathi P Wijeyesinghe, Milcah C Scott, Mathew R Semler, Clare Quarnstrom, Sara Hamilton Hart, David O’Connor, Jacob D Estes, Vaiva Vezys, and David Masopust
- Subjects
Immunology ,Immunology and Allergy - Abstract
Lymphocytic choriomeningitis virus (LCMV) is a natural mouse pathogen. LCMV Armstrong, an acutely resolved strain, and LCMV Clone13, a mutant that establishes chronic infection, have provided contrasting infection models that continue to inform the fundamental biology of T cell differentiation, regulation of exhaustion, and response to checkpoint blockade. Here, we describe LCMV Minnesota (LCMV-MN), which was transmitted to laboratory mice upon cohousing with pet shop mice and shares 80–95% amino acid homology with previously characterized LCMV strains. Infection of laboratory mice with purified LCMV-MN resulted in widely disseminated viral replication and viremia that was controlled within 15–30 days; which is of intermediate duration between LCMV Armstrong and Clone13. The magnitude of the LCMV-MN specific CD8+ T cell was maintained at much higher levels than that observed after LCMV Armstrong or Clone13 infections. LCMV-MN responding CD8+ T cells were further associated with significantly biased differentiation towards the recently described PD1+ CXCR5+ Tim-3lo stem-like CD8+ T cell population that was previously shown to be largely responsible for responsiveness to PD-1 inhibitory checkpoint blockade. In contrast to LCMV Clone13-induced responses, this subset persisted after resolution of LCMV-MN viremia, yet transcriptionally, phenotypically and functionally resembled PD1+ TCF1+ stem-like CD8+ T cells maintained by LCMV Clone13 infection. Together with existing models, LCMV-MN may contribute to a better understanding of the breadth of immune response in different chronic infections or tumor settings as well as the regulation of responsiveness to PD-1 blockade.
- Published
- 2020
23. Developmental plasticity allows outside-in immune responses by resident memory T cells
- Author
-
Clare F Quarnstrom, Raissa Fonseca, Lalit K Beura, Hazem E. Ghoneim, Yiping Fan, Caitlin C Zebley, Milcah C Scott, Nancy J Fares-Frederickson, Sathi P Wijeyesinghe, Emily A Thompson, Henrique Borges da Silva, Vaiva Vezys, Benjamin A Youngblood, and David Masopust
- Subjects
Immunology ,Immunology and Allergy - Abstract
Central memory T (TCM) cells patrol lymph nodes and perform conventional memory responses upon re-stimulation: proliferation, migration, and differentiation into diverse T cell subsets while also self-renewing. Resident memory T (TRM) cells are parked within single organs, share properties with terminal effectors, and contribute to rapid host protection. We observed that reactivated TRM cells rejoined the circulating pool. Epigenetic analyses revealed that TRM cells align closely with conventional memory T cell populations, bearing little resemblance to recently activated effectors. Fully differentiated TRM cells isolated from small intestine epithelium exhibited the potential to differentiate into TCM, TEM, and TRM cells upon recall. Ex-TRM cells, former intestinal TRM that rejoined the circulating pool, heritably maintained a predilection for homing back to their tissue of origin upon subsequent reactivation and a heightened capacity to re-differentiate into TRM cells. Thus, TRM cells can rejoin the circulation but are advantaged to re-form local TRM when called upon.
- Published
- 2020
24. Inhibition of autoimmune enteritis in IFABP-Ova mice by LCMV infection
- Author
-
Siddheshvar Bhela, J. Michael Stolley, Eyob Weyu, Clare Quarnstrom, Christine Nelson, and Vaiva Vezys
- Subjects
Immunology ,Immunology and Allergy - Abstract
Epidemiological data indicate that infections play a role in preventing autoimmunity. Thus, the decline in the incidences of infectious diseases and the increase in the frequency of autoimmune diseases also known as the hygiene hypothesis suggest that there might be a link between the two phenomena. In this study using the iFABP-Ova transgenic mouse model, that expresses ovalbumin in the small intestine, we showed that prior LCMV infection dampened self-reactive effector CD8 T cell responses and protected mice from enteric autoimmunity. LCMV specific memory CD8 T cells, generated after infection, were not required for this protection as elimination of these cells using a depleting antibody still protected the mice from enteric autoimmunity. Moreover, we found that infection induced suppression is specific to self antigen reactive CD8 T cells without affecting foreign antigen specific CD8 T cell responses. Lastly, we found that a similar suppression of self-reactive CD8 T cells occurs in iFABP-Ova mice when tolerant CD8 T cells are previously present. Thus there might be some similarities in the mechanism of suppression of self-reactive CD8 T cells by viral infections and tolerance generation. Taken together these data demonstrate that prior viral infections or tolerant CD8 T cells have the ability to suppress self-reactive autoimmune responses and provide protective effects without compromising immunity to foreign pathogens.
- Published
- 2020
25. Cutting Edge: Evidence for Nonvascular Route of Visceral Organ Immunosurveillance by T Cells
- Author
-
Vaiva Vezys, Emily A. Thompson, Jason S. Mitchell, Elise R. Breed, David Masopust, Elizabeth M. Steinert, Frances V. Sjaastad, Mengdi Guo, Lalit K. Beura, and Omar A. Adam
- Subjects
0301 basic medicine ,Male ,Pathology ,medicine.medical_specialty ,Lymphocyte ,Immunology ,Mice, Transgenic ,Genitalia, Male ,Reproductive Tract Infections ,Article ,Extracellular matrix ,03 medical and health sciences ,Peritoneal cavity ,Mice ,0302 clinical medicine ,Cell Movement ,Monitoring, Immunologic ,T-Lymphocyte Subsets ,medicine ,Immunology and Allergy ,Cytotoxic T cell ,Animals ,Receptor ,Peritoneal Cavity ,biology ,CD44 ,Extravasation ,Extracellular Matrix ,Immunosurveillance ,Mice, Inbred C57BL ,030104 developmental biology ,medicine.anatomical_structure ,Hyaluronan Receptors ,biology.protein ,030215 immunology - Abstract
Lymphocytes enter tissues from blood vessels through a well-characterized three-step process of extravasation. To our knowledge, nonvascular routes of lymphocyte entry have not been described. In this article, we report that Ag-experienced CD8 T cells in mice recirculate from blood through the peritoneal cavity. In the event of infection, Ag-experienced CD8 T cell subsets adhered to visceral organs, indicating potential transcapsular immunosurveillance. Focusing on the male genital tract (MGT), we observed Ag-experienced CD8 T cell migration from the peritoneal cavity directly to the infected MGT across the capsule, which was dependent on the extracellular matrix receptor CD44. We also observed that, following clearance of infection, the MGT retained functional resident memory CD8 T cells. These data suggest that recirculation through body cavities may provide T cells with opportunities for broad immunosurveillance and potential nonvascular mechanisms of entry.
- Published
- 2018
26. Cutting Edge: Identification of Autoreactive CD4+ and CD8+ T Cell Subsets Resistant to PD-1 Pathway Blockade
- Author
-
Clare F. Quarnstrom, Jason M. Schenkel, Marc K. Jenkins, Nathanael L. Sahli, Kevin C. Osum, Kristen E. Pauken, Tijana Martinov, Vaiva Vezys, Bruce R. Blazar, James Heffernan, Justin A. Spanier, Brian T. Fife, and Christine E. Nelson
- Subjects
CD4-Positive T-Lymphocytes ,T cell ,Programmed Cell Death 1 Receptor ,Immunology ,CD8-Positive T-Lymphocytes ,Biology ,B7-H1 Antigen ,Article ,Autoimmune Diseases ,Mice ,Interleukin 21 ,Mice, Inbred NOD ,Immune Tolerance ,medicine ,Animals ,Immunology and Allergy ,Cytotoxic T cell ,IL-2 receptor ,Antigen-presenting cell ,Clonal Anergy ,Mice, Knockout ,ZAP70 ,CD28 ,Cell Differentiation ,Natural killer T cell ,Disease Models, Animal ,medicine.anatomical_structure ,Cancer research ,Female ,Disease Susceptibility ,Signal Transduction - Abstract
Programmed death-1 (PD-1) promotes T cell tolerance. Despite therapeutically targeting this pathway for chronic infections and tumors, little is known about how different T cell subsets are affected during blockade. We examined PD-1/PD ligand 1 (PD-L1) regulation of self-antigen–specific CD4 and CD8 T cells in autoimmune-susceptible models. PD-L1 blockade increased insulin-specific effector CD4 T cells in type 1 diabetes. However, anergic islet-specific CD4 T cells were resistant to PD-L1 blockade. Additionally, PD-L1 was critical for induction, but not maintenance, of CD8 T cell intestinal tolerance. PD-L1 blockade enhanced functionality of effector T cells, whereas established tolerant or anergic T cells were not dependent on PD-1/PD-L1 signaling to remain unresponsive. This highlights the existence of Ag-experienced T cell subsets that do not rely on PD-1/PD-L1 regulation. These findings illustrate how positive treatment outcomes and autoimmunity development during PD-1/PD-L1 inhibition are linked to the differentiation state of a T cell.
- Published
- 2015
27. Cellular Immune Response Against Firefly Luciferase After Sleeping Beauty–Mediated Gene Transfer In Vivo
- Author
-
R. Scott McIvor, Stephen J. Russell, Kelly M. Podetz-Pedersen, Nikunj V. Somia, and Vaiva Vezys
- Subjects
Transposable element ,Immunity, Cellular ,Adoptive cell transfer ,Transposases ,Mice, SCID ,Biology ,Adoptive Transfer ,Molecular biology ,Mice, Inbred C57BL ,Transformation (genetics) ,Transformation, Genetic ,Immune system ,Luciferases, Firefly ,Mice, Inbred NOD ,In vivo ,Genetics ,Splenocyte ,Animals ,Humans ,Molecular Medicine ,Luciferase ,Molecular Biology ,Research Articles ,Transposase - Abstract
The Sleeping Beauty (SB) transposon system has been shown to mediate new gene sequence integration resulting in long-term expression. Here the effectiveness of hyperactive SB100X transposase was tested, and we found that hydrodynamic co-delivery of a firefly luciferase transposon (pT2/CaL) along with SB100X transposase (pCMV-SB100X) resulted in remarkably sustained, high levels of luciferase expression. However, after 4 weeks there was a rapid, animal-by-animal loss of luciferase expression that was not observed in immunodeficient mice. We hypothesized that this sustained, high-level luciferase expression achieved using the SB100X transposase elicits an immune response in pT2/CaL co-administered mice, which was supported by the rapid loss of luciferase expression upon challenge of previously treated animals and in naive animals adoptively transferred with splenocytes from previously treated animals. Specificity of the immune response to luciferase was demonstrated by increased cytokine expression in splenocytes after exposure to luciferase peptide in parallel with MHC I–luciferase peptide tetramer binding. This anti-luciferase immune response observed following continuous, high-level luciferase expression in vivo clearly impacts its use as an in vivo reporter. As both an immunogen and an extremely sensitive reporter, luciferase is also a useful model system for the study of immune responses following in vivo gene transfer and expression.
- Published
- 2014
28. Intravascular staining for discrimination of vascular and tissue leukocytes
- Author
-
Britnie R. James, Vaiva Vezys, Heungsup Sung, Kristin G. Anderson, Thomas S. Griffith, Daniel L. Barber, Lalit K. Beura, Katrin D. Mayer-Barber, Justin J. Taylor, Lindor Qunaj, and David Masopust
- Subjects
Cellular immunity ,Adaptive Immunity ,Biology ,Lymphocytic choriomeningitis ,medicine.disease_cause ,Article ,General Biochemistry, Genetics and Molecular Biology ,Autoimmunity ,Capillary Permeability ,Mice ,Immune system ,Immunity ,Leukocytes ,medicine ,Animals ,Lung ,B-Lymphocytes ,Staining and Labeling ,Mycobacterium tuberculosis ,medicine.disease ,Acquired immune system ,Immunity, Innate ,Staining ,medicine.anatomical_structure ,Immunology ,Biomarkers - Abstract
Characterization of the cellular participants in tissue immune responses is crucial to understanding infection, cancer, autoimmunity, allergy, graft rejection and other immunological processes. Previous reports indicate that leukocytes in lung vasculature fail to be completely removed by perfusion. Several studies suggest that intravascular staining may discriminate between tissue-localized and blood-borne cells in the mouse lung. Here we outline a protocol for the validation and use of intravascular staining to define innate and adaptive immune cells in mice. We demonstrate application of this protocol to leukocyte analyses in many tissues and we describe its use in the contexts of lymphocytic choriomeningitis virus and Mycobacterium tuberculosis infections or solid tumors. Intravascular staining and organ isolation usually takes 5-30 min per mouse, with additional time required for any subsequent leukocyte isolation, staining and analysis. In summary, this simple protocol should help enable interpretable analyses of tissue immune responses.
- Published
- 2014
29. Virus-specific memory T cells populate tumors and can be repurposed as a tumor immunotherapy
- Author
-
Pamela Rosato, Sathi Wijeyesinghe, Michael Stolley, Christine Nelson, Rachel L Davis, Luke S Manlove, Christopher A Pennell, Bruce R. Blazar, Clark C Chen, Melissa A Geller, Vaiva Vezys, and David Masopust
- Subjects
Immunology ,Immunology and Allergy - Abstract
The immunosuppressive tumor microenvironment limits the success of current immunotherapies. The host retains memory T cells specific for previous infections throughout the entire body that are capable of executing potent and immediate immunostimulatory functions. Here we show that virus-specific memory T cells extend their surveillance to mouse and human tumors. Reactivating these antiviral T cells can arrest growth of checkpoint blockade-resistant and poorly immunogenic tumors in mice after injecting adjuvant-free non-replicating viral peptides into tumors. Peptide mimics a viral reinfection event to memory CD8+ T cells, triggering antigen presentation and cytotoxic pathways within the tumor, activating dendritic cells and natural killer cells, and recruiting the adaptive immune system. Viral peptide treatment of ex vivo human tumors recapitulates immune activation gene expression profiles observed in mice. Lastly, peptide therapy renders resistant mouse tumors susceptible to PD-L1 blockade. Thus, re-stimulating known antiviral immunity may provide a unique therapeutic approach for cancer immunotherapy.
- Published
- 2019
30. Abstract B182: Repurposing antiviral T-cells to fight tumors
- Author
-
Christine E. Nelson, J. Michael Stolley, Melissa A. Geller, Sathi Wijeyesinghe, Luke S. Manlove, Clark C. Chen, Vaiva Vezys, Rachel L. Davis, David Masopust, Pamela C. Rosato, Christopher A. Pennell, and Bruce R. Blazar
- Subjects
Cancer Research ,Tumor microenvironment ,business.industry ,medicine.medical_treatment ,Immunology ,Cancer ,Immunotherapy ,Acquired immune system ,medicine.disease ,Immune system ,medicine.anatomical_structure ,Cancer immunotherapy ,Immunity ,medicine ,Cancer research ,business ,Lymph node - Abstract
Overcoming the immunosuppressive tumor microenvironment and localizing adoptive cell and checkpoint blockade therapies to solid tumors remain major impediments to successful cancer immunotherapy. Humans experience many viral infections. Once controlled, the host retains memory T-cells throughout the entire body to sense reinfection or recrudescence. Mouse models have demonstrated that when that same virus is reencountered, these T-cells sound an alarm that induces a local immunostimulatory environment that activates and recruits many arms of the immune system. We observed that, like healthy tissue, human tumors are commonly surveyed by memory T-cells specific for previously encountered viral infections. Antiviral T-cell immune surveillance of tumors was recapitulated in mouse cancer models. We tested and discovered that local delivery of adjuvant-free peptide, derived from previously encountered mouse viral infections, recapitulated the sensing and alarm T-cell function within the tumor: recruiting and activating both the innate and adaptive immune system. This approach induced intratumoral accumulation of granzyme B+ CD8+ T and NK cells, and activated dendritic cells within the tumor and subsequently within the tumor draining lymph node. In addition to stimulating the tumor microenvironment, preliminary data suggest activated antiviral T-cells directly killed peptide coated tumor cells. Viral peptide administration arrested rapidly growing and poorly immunogenic B16 melanomas in vivo and this treatment synergized with anti-PD-L1 checkpoint blockade to eliminate measurable tumors, and prevented recurrence in 34% of mice. Most cured mice rejected subsequent B16 tumor challenges at distant sites, indicating that effective systemic tumor-specific immunity was established. In support of the hypothesis that this approach could translate to human cancer immunotherapy, we found that viral peptide alarm therapy of freshly isolated human tumors drove similar immune activation to that observed in mice. This study demonstrates that natural and existing antiviral immunity can be repurposed to fight tumors without the need for adjuvant, vaccination, or personalized identification of immunogenic tumor neoantigens. Citation Format: Pamela C. Rosato, Sathi Wijeyesinghe, J. Michael Stolley, Christine Nelson, Rachel L. Davis, Luke S. Manlove, Christopher A. Pennell, Bruce R. Blazar, Clark C. Chen, Melissa A. Geller, Vaiva Vezys, David Masopust. Repurposing antiviral T-cells to fight tumors [abstract]. In: Proceedings of the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; Sept 30-Oct 3, 2018; New York, NY. Philadelphia (PA): AACR; Cancer Immunol Res 2019;7(2 Suppl):Abstract nr B182.
- Published
- 2019
31. Heterologous Vaccination and Checkpoint Blockade Synergize To Induce Antileukemia Immunity
- Author
-
Vaiva Vezys, Jason M. Schenkel, Michael A. Farrar, Luke S. Manlove, Kristen E. Pauken, Kezia R. Manlove, and Richard Thomas Williams
- Subjects
0301 basic medicine ,Nonsynonymous substitution ,Cell cycle checkpoint ,Immunology ,Population ,Heterologous ,Biology ,medicine.disease_cause ,Article ,03 medical and health sciences ,Mice ,0302 clinical medicine ,hemic and lymphatic diseases ,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma ,medicine ,Immunology and Allergy ,Missense mutation ,Animals ,education ,Mice, Knockout ,Mutation ,education.field_of_study ,Vaccination ,Cell Cycle Checkpoints ,medicine.disease ,Blockade ,Mice, Inbred C57BL ,Leukemia ,Disease Models, Animal ,030104 developmental biology ,030215 immunology - Abstract
Checkpoint blockade-based immunotherapies are effective in cancers with high numbers of nonsynonymous mutations. In contrast, current paradigms suggest that such approaches will be ineffective in cancers with few nonsynonymous mutations. To examine this issue, we made use of a murine model of BCR-ABL+ B-lineage acute lymphoblastic leukemia. Using a principal component analysis, we found that robust MHC class II expression, coupled with appropriate costimulation, correlated with lower leukemic burden. We next assessed whether checkpoint blockade or therapeutic vaccination could improve survival in mice with pre-established leukemia. Consistent with the low mutation load in our leukemia model, we found that checkpoint blockade alone had only modest effects on survival. In contrast, robust heterologous vaccination with a peptide derived from the BCR-ABL fusion (BAp), a key driver mutation, generated a small population of mice that survived long-term. Checkpoint blockade strongly synergized with heterologous vaccination to enhance overall survival in mice with leukemia. Enhanced survival did not correlate with numbers of BAp:I-Ab–specific T cells, but rather with increased expression of IL-10, IL-17, and granzyme B and decreased expression of programmed death 1 on these cells. Our findings demonstrate that vaccination to key driver mutations cooperates with checkpoint blockade and allows for immune control of cancers with low nonsynonymous mutation loads.
- Published
- 2016
32. Cutting Edge: Intravascular Staining Redefines Lung CD8 T Cell Responses
- Author
-
Angela Deisinger, Vaiva Vezys, Leo Lefrançois, Heungsup Sung, Cara N. Skon, Kristin G. Anderson, and David Masopust
- Subjects
Pathology ,medicine.medical_specialty ,CD8 Antigens ,T cell ,Pneumonia, Viral ,Immunology ,Spleen ,CD8-Positive T-Lymphocytes ,Lymphocytic Choriomeningitis ,Lymphocytic choriomeningitis ,Antibodies ,Article ,Mice ,Cell Movement ,medicine ,Animals ,Immunology and Allergy ,Cytotoxic T cell ,Respiratory system ,Lung ,Staining and Labeling ,biology ,medicine.disease ,Mice, Mutant Strains ,Capillaries ,Staining ,Mice, Inbred C57BL ,medicine.anatomical_structure ,Pertussis Toxin ,biology.protein ,Antibody - Abstract
Nonlymphoid T cell populations control local infections and contribute to inflammatory diseases, thus driving efforts to understand the regulation of their migration, differentiation, and maintenance. Numerous observations indicate that T cell trafficking and differentiation within the lung are starkly different from what has been described in most nonlymphoid tissues, including intestine and skin. After systemic infection, we found that >95% of memory CD8 T cells isolated from mouse lung via standard methods were actually confined to the pulmonary vasculature, despite perfusion. A respiratory route of challenge increased virus-specific T cell localization within lung tissue, although only transiently. Removing blood-borne cells from analysis by the simple technique of intravascular staining revealed distinct phenotypic signatures and chemokine-dependent trafficking restricted to Ag-experienced T cells. These results precipitate a revised model for pulmonary T cell trafficking and differentiation and a re-evaluation of studies examining the contributions of pulmonary T cells to protection and disease.
- Published
- 2012
33. Recalling good memories
- Author
-
David Masopust and Vaiva Vezys
- Subjects
Mucosal immunology ,Genitourinary system ,Immunity ,business.industry ,Immunology ,medicine ,Immunology and Allergy ,Inflammation ,medicine.symptom ,business - Published
- 2014
34. T Cells in Nonlymphoid Tissues Give Rise to Lymph-Node-Resident Memory T Cells
- Author
-
Mark Pierson, Sathi Wijeyesinghe, Brian T. Fife, Marissa Macchietto, Jason M. Schenkel, Emily A. Thompson, Pamela C. Rosato, Lalit K. Beura, David Masopust, Steven S. Shen, Jason S. Mitchell, and Vaiva Vezys
- Subjects
Antigens, Differentiation, T-Lymphocyte ,0301 basic medicine ,genetic structures ,Parabiosis ,Immunology ,chemical and pharmacologic phenomena ,CD8-Positive T-Lymphocytes ,Lymphocytic Choriomeningitis ,Biology ,Article ,Secondary lymphoid organs ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Antigens, CD ,medicine ,Animals ,Immunology and Allergy ,Lectins, C-Type ,Lymph node ,integumentary system ,CD69 ,hemic and immune systems ,Phenotype ,Cell biology ,Mice, Inbred C57BL ,Immunosurveillance ,030104 developmental biology ,Infectious Diseases ,medicine.anatomical_structure ,Female ,Lymph Nodes ,Lymph ,Immunologic Memory ,CD8 ,030215 immunology - Abstract
Summary Immunosurveillance of secondary lymphoid organs (SLO) is performed by central memory T cells that recirculate through blood. Resident memory T (Trm) cells remain parked in nonlymphoid tissues and often stably express CD69. We recently identified Trm cells within SLO, but the origin and phenotype of these cells remains unclear. Using parabiosis of "dirty" mice, we found that CD69 expression is insufficient to infer stable residence of SLO Trm cells. Restimulation of nonlymphoid memory CD8 + T cells within the skin or mucosa resulted in a substantial increase in bona fide Trm cells specifically within draining lymph nodes. SLO Trm cells derived from emigrants from nonlymphoid tissues and shared some transcriptional and phenotypic signatures associated with nonlymphoid Trm cells. These data indicate that nonlymphoid cells can give rise to SLO Trm cells and suggest vaccination strategies by which memory CD8 + T cell immunosurveillance can be regionalized to specific lymph nodes.
- Published
- 2018
35. Dynamic T cell migration program provides resident memory within intestinal epithelium
- Author
-
E. John Wherry, Daniel Choo, David Masopust, Kathryn A. Fraser, Kenneth A. Newell, Kerry A. Casey, Daniel L. Barber, Jaikumar Duraiswamy, Rafi Ahmed, Eugene C. Butcher, Kim S. Kawamura, Jun Wang, Vaiva Vezys, Richard J. Webby, Rama Akondy, and Volker Brinkmann
- Subjects
T-Lymphocytes ,T cell ,Immunology ,Receptors, Lymphocyte Homing ,Antigens, CD34 ,Spleen ,CD8-Positive T-Lymphocytes ,Biology ,Lymphocyte Activation ,Article ,Mice ,Intestinal mucosa ,Cell Movement ,medicine ,Animals ,Humans ,Immunology and Allergy ,Intestinal Mucosa ,Yellow Fever Vaccine ,Intestinal epithelium ,Mice, Inbred C57BL ,medicine.anatomical_structure ,Lymphatic system ,T cell migration ,Immunization ,Immunologic Memory ,Memory T cell ,Homing (hematopoietic) - Abstract
Migration to intestinal mucosa putatively depends on local activation because gastrointestinal lymphoid tissue induces expression of intestinal homing molecules, whereas skin-draining lymph nodes do not. This paradigm is difficult to reconcile with reports of intestinal T cell responses after alternative routes of immunization. We reconcile this discrepancy by demonstrating that activation within spleen results in intermediate induction of homing potential to the intestinal mucosa. We further demonstrate that memory T cells within small intestine epithelium do not routinely recirculate with memory T cells in other tissues, and we provide evidence that homing is similarly dynamic in humans after subcutaneous live yellow fever vaccine immunization. These data explain why systemic immunization routes induce local cell-mediated immunity within the intestine and indicate that this tissue must be seeded with memory T cell precursors shortly after activation.
- Published
- 2010
36. Memory CD8 T-cell compartment grows in size with immunological experience
- Author
-
Vaiva Vezys, Kerry A. Casey, Gibson Lanier, Andrew J. Yates, David Masopust, Rustom Antia, and Rafi Ahmed
- Subjects
Vaccination ,Cellular immunity ,Multidisciplinary ,Immune system ,Effector ,Immunity ,Immunology ,Cytotoxic T cell ,T lymphocyte ,Biology ,CD8 - Abstract
Memory CD8 T cells, generated by natural pathogen exposure or intentional vaccination, protect the host against specific viral infections. It has long been proposed that the number of memory CD8 T cells in the host is inflexible, and that individual cells are constantly competing for limited space. Consequently, vaccines that introduce over-abundant quantities of memory CD8 T cells specific for an agent of interest could have catastrophic consequences for the host by displacing memory CD8 T cells specific for all previous infections. To test this paradigm, we developed a vaccination regimen in mice that introduced as many new long-lived memory CD8 T cells specific for a single vaccine antigen as there were memory CD8 T cells in the host before vaccination. Here we show that, in contrast to expectations, the size of the memory CD8 T-cell compartment doubled to accommodate these new cells, a change due solely to the addition of effector memory CD8 T cells. This increase did not affect the number of CD4 T cells, B cells or naive CD8 T cells, and pre-existing memory CD8 T cells specific for a previously encountered infection were largely preserved. Thus, the number of effector memory CD8 T cells in the mammalian host adapts according to immunological experience. Developing vaccines that abundantly introduce new memory CD8 T cells should not necessarily ablate pre-existing immunity to other infections.
- Published
- 2008
37. A brief history of CD8 T cells
- Author
-
E. John Wherry, Rafi Ahmed, David Masopust, and Vaiva Vezys
- Subjects
Immunology ,Cellular Immunology ,CD8-Positive T-Lymphocytes ,History, 20th Century ,Biology ,medicine.disease_cause ,Acquired immune system ,Major histocompatibility complex ,History, 21st Century ,Autoimmunity ,Vaccination ,Immune system ,Allergy and Immunology ,medicine ,biology.protein ,Animals ,Humans ,Immunology and Allergy ,Cytotoxic T cell ,Antibody - Abstract
CD8 T cells comprise a powerful branch of the adaptive immune system, yet were not formally recognized until long after the discovery of antibody. CD8 T cells contribute to the eradication of intracellular infections and to the control of many chronic infections. There is tempered optimism that CD8 T cell memory elicited via vaccination may hold the key to manufacturing protective immunity against pathogens that cause chronic infections in humans. The specificity and destructive capabilities of CD8 T cells may also be harnessed for the eradication of tumors. However, CD8 T cells also contribute to a variety of clinical difficulties such as immune mediated pathology, rejection of organ transplants, and autoimmunity. Clearly, learning how to safely generate protective long-lived CD8 T cell memory and how to control or eliminate specific unwanted responses could deliver substantial clinical rewards, and there is a great need for continued research on the biology and therapeutic potential of these cells. Herein, we recount the historical developments leading to the discovery of CD8 T cells, highlight a few of the important discoveries that have followed, and discuss some of the critical issues on the horizon.
- Published
- 2007
38. Analysis of CD8+ T cell-mediated anti-viral responses in mice with targeted deletions of the M1 or M5 muscarinic cholinergic receptors
- Author
-
Jürgen Wess, James C. Zimring, David Masopust, Maxime Desmarets, and Vaiva Vezys
- Subjects
Male ,Time Factors ,T cell ,CD8-Positive T-Lymphocytes ,Biology ,Vesicular stomatitis Indiana virus ,Article ,General Biochemistry, Genetics and Molecular Biology ,Mice ,Interleukin 21 ,Antigen ,medicine ,Animals ,Lymphocytic choriomeningitis virus ,Cytotoxic T cell ,IL-2 receptor ,General Pharmacology, Toxicology and Pharmaceutics ,Receptor ,Antigen-presenting cell ,Mice, Knockout ,Receptor, Muscarinic M5 ,Receptor, Muscarinic M1 ,General Medicine ,Flow Cytometry ,Virology ,Molecular biology ,Mice, Inbred C57BL ,medicine.anatomical_structure ,Virus Diseases ,Female ,Gene Deletion ,CD8 - Abstract
A number of studies have demonstrated that non-neuronal acetylcholine can play a role in the regulation of T cell function. Recently, we reported that CD8(+) T cells, from mice with a targeted deletion of the M(1) muscarinic receptor, had a defect in differentiating into cytolytic T lymphocytes when stimulated in vitro. In the current report, we analyze the in vivo function of CD8(+) T cells from mice with targeted deletions of either M(1) or M(5) muscarinic receptors. M(1) or M(5) knockout mice were infected with either lymphocytic choriomeningitis virus or vesicular stomatitis virus. Expansion of anti-viral CD8(+) T cells was monitored by staining with tetramer reagents specific for the immunodominant peptides of the viruses. No defect in expansion of CD8(+) T cells was observed in either M(1) or M(5) knockout mice. The extent to which one can draw a generalized conclusion that M(1) and M(5) are not involved in anti-viral immunity depends upon issues of antigen strength, genetic background, induction of redundant receptors, and the potential for qualitative defects in the expanded CD8(+) T cells.
- Published
- 2007
39. Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection
- Author
-
Christopher C. Kemball, Christian P. Larsen, Leigh A. O’Mara, Thomas C. Pearson, David Masopust, Rafi Ahmed, Aron E. Lukacher, Daniel L. Barber, and Vaiva Vezys
- Subjects
T cell ,Immunology ,CD8-Positive T-Lymphocytes ,Mice ,03 medical and health sciences ,Interleukin 21 ,0302 clinical medicine ,Antigen ,medicine ,Animals ,Lymphocytic choriomeningitis virus ,Immunology and Allergy ,Cytotoxic T cell ,Antigen-presenting cell ,Antigens, Viral ,030304 developmental biology ,0303 health sciences ,CD40 ,biology ,Brief Definitive Report ,Cell Differentiation ,Flow Cytometry ,Natural killer T cell ,Virology ,3. Good health ,Mice, Inbred C57BL ,medicine.anatomical_structure ,Virus Diseases ,Interleukin 12 ,biology.protein ,Brief Definitive Reports ,Female ,Polyomavirus ,030215 immunology - Abstract
Numerous microbes establish persistent infections, accompanied by antigen-specific CD8 T cell activation. Pathogen-specific T cells in chronically infected hosts are often phenotypically and functionally variable, as well as distinct from T cells responding to nonpersistent infections; this phenotypic heterogeneity has been attributed to an ongoing reencounter with antigen. Paradoxically, maintenance of memory CD8 T cells to acutely resolved infections is antigen independent, whereas there is a dependence on antigen for T cell survival in chronically infected hosts. Using two chronic viral infections, we demonstrate that new naive antigen-specific CD8 T cells are primed after the acute phase of infection. These newly recruited T cells are phenotypically distinct from those primed earlier. Long-lived antiviral CD8 T cells are defective in self-renewal, and lack of thymic output results in the decline of virus-specific CD8 T cells, indicating that newly generated T cells preserve antiviral CD8 T cell populations during chronic infection. These findings reveal a novel role for antigen in maintaining virus-specific CD8 T cells during persistent infection and provide insight toward understanding T cell differentiation in chronic infection.
- Published
- 2006
40. Lymphocytic choriomeningitis virus persistence promotes effector-like memory differentiation and enhances mucosal T cell distribution
- Author
-
Jason M. Schenkel, Jeremiah J. Locquiao, Kristin G. Anderson, Marion Pepper, Kathryn A. Fraser, David Masopust, Lalit K. Beura, and Vaiva Vezys
- Subjects
Antigens, Differentiation, T-Lymphocyte ,CD4-Positive T-Lymphocytes ,Receptors, CXCR4 ,Integrin beta Chains ,T cell ,Integrin alpha4 ,Immunology ,chemical and pharmacologic phenomena ,Biology ,CD8-Positive T-Lymphocytes ,Lymphocytic Choriomeningitis ,Lymphocytic choriomeningitis ,Granzymes ,Interleukin 21 ,Mice ,Antigen ,Antigens, CD ,Cell Movement ,medicine ,Immunology and Allergy ,Cytotoxic T cell ,Animals ,Lymphocytic choriomeningitis virus ,Lectins, C-Type ,Intestinal Mucosa ,Immunity, Mucosal ,Cell Biology ,medicine.disease ,Virology ,Granzyme B ,medicine.anatomical_structure ,Gene Expression Regulation ,Organ Specificity ,T cell migration ,Female ,Immunologic Memory ,Integrin alpha Chains ,CD8 - Abstract
Vaccines are desired that maintain abundant memory T cells at nonlymphoid sites of microbial exposure, where they may be anatomically positioned for immediate pathogen interception. Here, we test the impact of antigen persistence on mouse CD8 and CD4 T cell distribution and differentiation by comparing responses to infections with different strains of LCMV that cause either acute or chronic infections. We used in vivo labeling techniques that discriminate between T cells present within tissues and abundant populations that fail to be removed from vascular compartments, despite perfusion. LCMV persistence caused up to ∼30-fold more virus-specific CD8 T cells to distribute to the lung compared with acute infection. Persistent infection also maintained mucosal-homing α4β7 integrin expression, higher granzyme B expression, alterations in the expression of the TRM markers CD69 and CD103, and greater accumulation of virus-specific CD8 T cells in the large intestine, liver, kidney, and female reproductive tract. Persistent infection also increased LCMV-specific CD4 T cell quantity in mucosal tissues and induced maintenance of CXCR4, an HIV coreceptor. This study clarifies the relationship between viral persistence and CD4 and CD8 T cell distribution and mucosal phenotype, indicating that chronic LCMV infection magnifies T cell migration to nonlymphoid tissues.
- Published
- 2014
41. A cytokine promoter/yellow fluorescent protein reporter transgene serves as an early activation marker of lymphocyte subsets
- Author
-
Marianne J. Skeen, Aron E. Lukacher, Hyseuk Yoon, Shantha Kumar, Brian D. Evavold, Yaffa Adiri, H. Kirk Ziegler, Vaiva Vezys, and Jeremy M. Boss
- Subjects
Yellow fluorescent protein ,Ovalbumin ,Recombinant Fusion Proteins ,Lymphocyte ,medicine.medical_treatment ,Transgene ,Immunology ,DNA, Recombinant ,Gene Expression ,Mice, Transgenic ,In Vitro Techniques ,Lymphocyte Activation ,Tacrolimus ,Mice ,Bacterial Proteins ,Genes, Reporter ,medicine ,Animals ,Cytotoxic T cell ,Antigens ,Promoter Regions, Genetic ,Reporter gene ,Base Sequence ,biology ,Ionomycin ,CD28 ,Molecular biology ,Lymphocyte Subsets ,Peptide Fragments ,Mice, Inbred C57BL ,Transplantation ,Luminescent Proteins ,medicine.anatomical_structure ,Cytokine ,Cyclosporine ,biology.protein ,Tetradecanoylphorbol Acetate ,Interleukin-4 ,Biomarkers - Abstract
A mouse containing an IL-4 promoter linked to the yellow fluorescent protein (YFP) reporter transgene was created to follow aspects of lymphocyte development and function. Following stimulation with phorbol 12-myristate 13-acetate and ionomycin, anti-CD3/CD28, antigen-specific peptide, or allogeneic cells, both CD4 and CD8 T cells expressed the transgene within 24 h in a manner that was consistent with cellular activation markers. Transgene induction was inhibited by cyclosporine and FK506, suggesting that its activation occurs in an NFAT-dependent manner. B lymphocytes were also able to express the transgene when stimulated with LPS. This induction was inhibited in part by rapamycin. The results suggest that this transgene can function as an indicator of lymphocyte activation. Because YFP is not toxic and requires no preparation of the cells to view the reporter gene, this system provides a unique tool to follow lymphocyte activation in a number of model systems, such as those involving transplantation, allergy, and vaccine development.
- Published
- 2005
42. Late Priming and Variability of Epitope-Specific CD8+ T Cell Responses during a Persistent Virus Infection
- Author
-
Vaiva Vezys, Christian P. Larsen, Thomas C. Pearson, Aron E. Lukacher, Christopher C. Kemball, and Eun D.Han Lee
- Subjects
medicine.medical_treatment ,T cell ,Immunology ,Epitopes, T-Lymphocyte ,Priming (immunology) ,CD8-Positive T-Lymphocytes ,Biology ,Epitope ,Immunophenotyping ,Mice ,Mice, Congenic ,Interleukin 21 ,T-Lymphocyte Subsets ,Cell Line, Tumor ,medicine ,Animals ,Immunology and Allergy ,Cytotoxic T cell ,Avidity ,Bone Marrow Transplantation ,Mice, Knockout ,Polyomavirus Infections ,Chimera ,Immunodominant Epitopes ,Cell Differentiation ,Virology ,Virus Latency ,Mice, Inbred C57BL ,Tumor Virus Infections ,Cytokine ,medicine.anatomical_structure ,Female ,Polyomavirus ,Immunologic Memory ,CD8 - Abstract
Control of persistently infecting viruses requires that antiviral CD8+ T cells sustain their numbers and effector function. In this study, we monitored epitope-specific CD8+ T cells during acute and persistent phases of infection by polyoma virus, a mouse pathogen that is capable of potent oncogenicity. We identified several novel polyoma-specific CD8+ T cell epitopes in C57BL/6 mice, a mouse strain highly resistant to polyoma virus-induced tumors. Each of these epitopes is derived from the viral T proteins, nonstructural proteins produced by both productively and nonproductively (and potentially transformed) infected cells. In contrast to CD8+ T cell responses described in other microbial infection mouse models, we found substantial variability between epitope-specific CD8+ T cell responses in their kinetics of expansion and contraction during acute infection, maintenance during persistent infection, as well as their expression of cytokine receptors and cytokine profiles. This epitope-dependent variability also extended to differences in maturation of functional avidity from acute to persistent infection, despite a narrowing in TCR repertoire across all three specificities. Using a novel minimal myeloablation-bone marrow chimera approach, we visualized priming of epitope-specific CD8+ T cells during persistent virus infection. Interestingly, epitope-specific CD8+ T cells differed in CD62L-selectin expression profiles when primed in acute or persistent phases of infection, indicating that the context of priming affects CD8+ T cell heterogeneity. In summary, persistent polyoma virus infection both quantitatively and qualitatively shapes the antiviral CD8+ T cell response.
- Published
- 2005
43. Infection induces friendly fire
- Author
-
Vaiva Vezys and David Masopust
- Subjects
Multidisciplinary ,animal diseases ,food and beverages ,Inflammatory Bowel Diseases ,chemical and pharmacologic phenomena ,biochemical phenomena, metabolism, and nutrition ,Biology ,Microbiology ,Immune tolerance ,Immune system ,Mucosal immunology ,Gut bacteria ,Immunology ,biology.protein ,bacteria ,Pathogen ,Immunologic memory ,Flagellin - Abstract
Our immune system usually ignores 'friendly' gut bacteria. But when infection with a pathogen damages the intestine's mucosal lining, the resident microbes can invade the body, inducing immune responses directed at themselves.
- Published
- 2012
44. Tissue-Level Regulation of Th1 and Th2 Primary and Memory CD4 T Cells in Response to Listeria Infection
- Author
-
Kristina Williams, David F. Tough, Vaiva Vezys, Amanda L. Marzo, and Leo Lefrançois
- Subjects
Lymphoid Tissue ,CD40 Ligand ,Immunology ,Spleen ,Listeria infection ,Mice ,Th2 Cells ,Intestinal mucosa ,medicine ,Animals ,Immunology and Allergy ,Listeriosis ,Intestinal Mucosa ,Lung ,Lymph node ,Cells, Cultured ,Mice, Knockout ,Mouth ,CD40 ,biology ,Effector ,Th1 Cells ,medicine.disease ,biology.organism_classification ,Mice, Inbred C57BL ,Kinetics ,medicine.anatomical_structure ,Lymphatic system ,Liver ,Organ Specificity ,biology.protein ,Listeria ,Cytokines ,Immunologic Memory - Abstract
Ag-specific Th1 and Th2 cytokine-producing CD4 T cells were quantitated in secondary lymphoid and tertiary tissues following oral Listeria monocytogenes infection. Although the response to Listeria was previously believed to be predominately Th1 like, CD4 T cells producing IL-4 or IL-5 comprised a substantial proportion of the overall primary and memory response. The frequency of IFN-γ-, IL-4-, or IL-5-producing primary effector or memory CD4 T cells was significantly higher in lung, liver, and intestinal lamina propria (LP) as compared with spleen and lymph node. However, maximum numbers of IL-4- and IL-5-producing cells were detected in the LP several days after the peak of the Th1 response, and IL-5 production was skewed toward the mucosal tissues. Remarkably, the recall response resulted in sustained Th1 and Th2 responses in tertiary, but not lymphoid tissues and long-term retention of Th1 and Th2 memory cells in equal proportions in the LP. Finally, CD40 ligand was essential for induction of IFN-γ in the spleen and LP, but not in the liver and lung, while the IL-4 response required CD40 ligand only in the spleen. Therefore, the rules governing the effector phenotype, and the overall magnitude of the CD4 response, are regulated at the level of individual tissues.
- Published
- 2002
45. Harnessing tissue resident memory T cells to combat solid tumors
- Author
-
Pamela Rosato, Luke Manlove, Christine Nelson, Christopher Pennell, Vaiva Vezys, and David Masopust
- Subjects
Immunology ,Immunology and Allergy - Abstract
The immunosuppressive tumor microenvironment is barrier to successful cancer therapies. Newly discovered tissue resident memory CD8+ T cells (TRM) function to create a potent immunostimulatory environment to protect against local reinfection. As TRM are present in abundance in nearly every tissue and can be triggered by cognate peptide alone, without adjuvant, we tested whether we could hijack infection-specific TRM in tumors to reverse the immunosuppressive tumor microenvironment and enhance existing immunotherapies. Mice with established vesicular stomatitis virus (VSV)-specific skin TRM were challenged with the transplantable B16 melanoma cell line. We find VSV-specific CD8+ T cells within established tumors and by 12 hours of cognate peptide delivery, these cells upregulate IFNγ, CD25, and granzyme B. This led to 1) a 10-fold increase in intratumoral NK cells, 2) bystander memory CD8+ T cell recruitment to the tumor, 3) tumor NK cell and CD8+ T cell activation through granzyme B upregulation and 4) DC activation in tumor draining lymph nodes through CCR7 and CD86 upregulation. Ongoing studies using transplantable and autochthonous melanoma models are testing whether TRM immunotherapy synergizes with CAR T cell and checkpoint blockade immunotherapies for eradication of recalcitrant tumors. These results demonstrate proof of principal efficacy for exploiting infection-specific TRM as a tumor immunotherapy.
- Published
- 2017
46. Visualizing antigen-specific CD8 T cell dynamics in the small intestine
- Author
-
Emily A Thompson, Jason Mitchell, Lalit K Beura, Christine Nelson, Brian T Fife, and Vaiva Vezys
- Subjects
Immunology ,Immunology and Allergy - Abstract
The small intestine (SI) represents the largest mucosal barrier between the environment and the host. As such, the SI limits both normal and pathogenic microbe invasion and must balance immune tolerance and activation. CD8ab T cells constitute a dominant lymphocyte population in the SI and contribute to both of these processes but detailed investigation into their in situ behavior in response to various stimuli is lacking. We visualized Ag-specific CD8 T cell migration in the SI using two-photon microscopy to understand CD8 T cell immunosurveillance. We found that pathogen-specific CD8 T cells are initially slowed early after infection but regain motility directly after Ag clearance. At a memory time point, CD8 T cells exhibited slower migration concurrent with acquisition of a resident memory phenotype. Current studies are focused on determining what is required for CD8 T cell motility throughout the course of infection. Additionally, as tolerance reversal and expansion of self-specific CD8 T cells has recently become a focus of cancer therapy, we characterized in situ behavior of self-specific CD8 T cells. Using a mouse expressing a model Ag in the SI as a self-protein, we observed self-specific CD8 T cells before and after tolerance reversal. Tolerant CD8 T cells migrate significantly faster than pathogen-specific cells at acute time points after infection. Contrastingly, ex-tolerant CD8 T cells were comparable to pathogen-specific CD8 T cells indicating that indeed their in situ scanning behavior had been altered upon tolerance reversal. These observations have provided valuable insight into CD8 T cell motility within the SI and can inform targeted treatment options and vaccines to ensure effective immunosurveillance of this tissue.
- Published
- 2017
47. Utilizing self-specific CD8 T cells for the treatment of cancer
- Author
-
Christine Nelson, Clare Quarnstrom, Emily Thompson, and Vaiva Vezys
- Subjects
Immunology ,Immunology and Allergy - Abstract
CD8 T cells are potent effectors that monitor the body for infections as well as malignancies. CD8 T cell infiltration into tumors is correlated with better prognoses in many cancers. However, the tumor microenvironment is often toleragenic, which treatments like checkpoint inhibitors seek to overcome. Such treatments have been met with some success, but their benefits remain elusive for a subset of patients. Using a strict model of tolerance to intestinal self-antigen, we show that newly activated CD8 T cells respond best to checkpoint blockade therapy, while CD8 T cells in a toleragenic environment, even for a short time, do not respond. We have developed a therapeutic vaccination strategy that generates a targeted CD8 T cell response with renewed susceptibility to checkpoint blockade. Using heterologous prime boost vaccination model, we have refined tolerance reversal to a subset of self-antigen specific CD8 T cells, and eliminated the need for broadly immunostimulatory treatments. This model has been used to reverse tolerance in CD8 T cells specific for engineered antigens in the small intestine as well as naturally occurring self-antigens in the skin. The expanded populations of skin-specific CD8 T cells can be utilized for the treatment of melanoma. These melanocyte-specific CD8 T cells are functional and generate tissue resident memory (Trm) populations throughout the body, including the skin. Additionally, melanocyte-specific CD8 T cells can cooperate with neo-antigen specific CD8 T cells to aid in tumor clearance. By investigating tolerance reversal in self-specific CD8 T cells we have uncovered ways to improve upon current anti-cancer treatments and developed potentially translatable anti-cancer vaccine strategies.
- Published
- 2017
48. Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue
- Author
-
David Masopust, Vaiva Vezys, Leo Lefrançois, and Amanda L. Marzo
- Subjects
Lymphoid Tissue ,Ovalbumin ,T cell ,Population ,CD8-Positive T-Lymphocytes ,Biology ,Lymphocyte Activation ,Vesicular stomatitis Indiana virus ,Mice ,Immune system ,Cell Movement ,T-Lymphocyte Subsets ,Rhabdoviridae Infections ,Intestine, Small ,medicine ,Animals ,Cytotoxic T cell ,Listeriosis ,IL-2 receptor ,education ,Lung ,Cells, Cultured ,education.field_of_study ,Multidisciplinary ,Effector ,H-2 Antigens ,T lymphocyte ,Flow Cytometry ,Listeria monocytogenes ,Cell biology ,Mice, Inbred C57BL ,Phenotype ,medicine.anatomical_structure ,Liver ,Immunology ,Immunologic Memory ,CD8 - Abstract
Many intracellular pathogens infect a broad range of host tissues, but the importance of T cells for immunity in these sites is unclear because most of our understanding of antimicrobial T cell responses comes from analyses of lymphoid tissue. Here, we show that in response to viral or bacterial infection, antigen-specific CD8 T cells migrated to nonlymphoid tissues and were present as long-lived memory cells. Strikingly, CD8 memory T cells isolated from nonlymphoid tissues exhibited effector levels of lytic activity directly ex vivo, in contrast to their splenic counterparts. These results point to the existence of a population of extralymphoid effector memory T cells poised for immediate response to infection.
- Published
- 2001
49. Expression of Intestine-Specific Antigen Reveals Novel Pathways of CD8 T Cell Tolerance Induction
- Author
-
Sara Olson, Leo Lefrançois, and Vaiva Vezys
- Subjects
Ovalbumin ,CD8 Antigens ,Immunology ,Mice, Transgenic ,Inflammation ,CD8-Positive T-Lymphocytes ,Biology ,Immune tolerance ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Antigen ,Immune Tolerance ,medicine ,Animals ,Immunology and Allergy ,Cytotoxic T cell ,Intestinal Mucosa ,Immunity, Mucosal ,030304 developmental biology ,0303 health sciences ,Gene Transfer Techniques ,Molecular biology ,Epithelium ,3. Good health ,Cell biology ,Mice, Inbred C57BL ,Tolerance induction ,Infectious Diseases ,medicine.anatomical_structure ,Organ Specificity ,biology.protein ,medicine.symptom ,CD8 ,030215 immunology - Abstract
Reactivity to intestinal epithelium-specific antigen was studied by transgenic expression of cytosolic ovalbumin controlled by an enterocyte-specific promoter. Transferred OVA-specific CD8 cells (OT-I) preferentially expanded in mucosal lymphoid tissues and the epithelium but failed to cause tissue damage. In contrast, concomitant VSV-ova infection induced OT-I-mediated epithelial cell destruction that correlated with antigen density. OT-I cells retained in the epithelium exhibited high levels of lytic activity but were unable to produce cytokines. The mice were systemically tolerant to OVA since endogenous CD8 cells were nonresponsive to VSV-ova infection. Thus, intestinal antigen gained access to peripheral tissues via absorption from effete epithelial cells. This system demonstrated a requirement for inflammation to drive pathogenic autoreactivity against enterocytes and identified pathways of intestine-specific immunoregulation.
- Published
- 2000
50. Regulation of C-C chemokine production by murine T cells by CD28/B7 costimulation
- Author
-
Herold, K. C., Lu, J., Rulifson, I., Vaiva Vezys, Taub, D., Grusby, M. J., and Bluestone, J. A.
- Subjects
Immunology ,Immunology and Allergy - Abstract
C-C chemokines play an important role in recruitment of T lymphocytes to inflammatory sites. T lymphocytes secrete chemokines, but the activation requirements for chemokine production by T cells are uncertain. We studied the regulation of C-C chemokine production by CD28 costimulatory signals by murine T lymphocytes. Splenocytes from BALB/c mice cultured with anti-CD3 mAb expressed macrophage-inflammatory protein (MIP)-1alpha mRNA and secreted MIP-1alpha, which was inhibited by anti-B7-1 plus anti-B7-2 mAbs. MIP-1alpha production by Ag-stimulated T cells from DO.11.10 TCR transgenic mice was augmented by anti-CD28 mAb and increased compared with DO.11.10/CD28(-/-) cells. When T cell costimulation was provided by IL-2, MIP-1alpha was not enhanced. Studies with IL-2, IL-4, STAT4, and STAT6 knock-out mice suggested that chemokine production is controlled by pathways different from those regulating T cell differentiation. Thus, CD28 costimulation may amplify an immune response by stimulating T cell survival, proliferation, and production of chemokines that recruit T cells to inflammatory sites.
- Published
- 1997
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.